Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

An intriguing new lead on Huntington's disease.

Barinaga M.

Science. 1996 Mar 1;271(5253):1233-4. No abstract available.

PMID:
8638101
2.

New clues found to Huntington's.

Barinaga M.

Science. 1995 Nov 17;270(5239):1110. No abstract available.

PMID:
7502028
3.

The enigma of Huntington's disease.

Cattaneo E, Rigamonti D, Zuccato C.

Sci Am. 2002 Dec;287(6):92-7. No abstract available.

PMID:
12469651
4.

Characterising the Huntington's disease gene product.

Wood J, MacMillan JC, Thomas P, Lowenstein PR, Harper PS, Jones AL.

Biochem Soc Trans. 1995 Nov;23(4):595S. No abstract available.

PMID:
8654780
5.

Huntington's disease gene product, huntingtin, associates with microtubules in vitro.

Tukamoto T, Nukina N, Ide K, Kanazawa I.

Brain Res Mol Brain Res. 1997 Nov;51(1-2):8-14.

PMID:
9427501
6.

Molecular aspects of Huntington's disease.

Walling HW, Baldassare JJ, Westfall TC.

J Neurosci Res. 1998 Nov 1;54(3):301-8. Review.

PMID:
9819135
7.

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM.

Proc Natl Acad Sci U S A. 1996 May 14;93(10):5037-42.

8.

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.

Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, Vance JM, Strittmatter WJ.

Nat Med. 1996 Mar;2(3):347-50.

PMID:
8612237
9.

Polyglutamine expansion and Huntington's disease.

Bates GP, Mangiarini L, Wanker EE, Davies SW.

Biochem Soc Trans. 1998 Aug;26(3):471-5. Review. No abstract available.

PMID:
9765898
10.

Huntingtin aggregates ask to be eaten.

Thoreen CC, Sabatini DM.

Nat Genet. 2004 Jun;36(6):553-4. No abstract available.

PMID:
15167929
11.

Neurodegenerative disease: neuron protection agency.

Orr HT.

Nature. 2004 Oct 14;431(7010):747-8. No abstract available.

PMID:
15483586
12.

In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.

Hackam AS, Singaraja R, Zhang T, Gan L, Hayden MR.

Hum Mol Genet. 1999 Jan;8(1):25-33.

PMID:
9887328
13.

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.

Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA.

Science. 2001 Mar 23;291(5512):2423-8.

14.

Neurodegeneration. Huntington's research points to possible new therapies.

Marx J.

Science. 2005 Oct 7;310(5745):43-5. No abstract available.

PMID:
16210515
15.

Hope for Huntington's from an old antibiotic.

Ashraf H.

Drug Discov Today. 2005 Dec;10(23-24):1582-3. No abstract available.

PMID:
16376812
16.

Reversing neurodegeneration: a promise unfolds.

Orr HT, Zoghbi HY.

Cell. 2000 Mar 31;101(1):1-4. Review. No abstract available.

17.

Hunting in the calm before the storm.

Bates G, Eberwine J.

Nat Genet. 2000 Aug;25(4):365-6. No abstract available.

PMID:
10932169
18.

Huntington's disease: genetics lends a hand.

Palfi S, Jarraya B.

Nature. 2008 Jun 12;453(7197):863-4. doi: 10.1038/nature06365. No abstract available.

PMID:
18488017
19.

Huntington's disease: flipping a switch on huntingtin.

Greiner ER, Yang XW.

Nat Chem Biol. 2011 Jun 17;7(7):412-4. doi: 10.1038/nchembio.604. No abstract available.

PMID:
21685885
20.

Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragments.

Rubinsztein DC, Huntington JA.

Exp Neurol. 2006 Jun;199(2):243-4. Epub 2006 Apr 24. Review. No abstract available.

PMID:
16631742

Supplemental Content

Support Center